Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference being held in New York on December 3-5, 2024.
WATERTOWN, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference being held in New York on December 3-5, 2024.
|
Piper Sandler 36th Annual Healthcare Conference details: | |
| Meetings: | Presentation and one-on-one meetings |
| Presentation Date: | Tuesday, December 3rd, 2024 |
| Presentation Time: | 12:30 PM ET |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
| Piper Sandler 36th Annual Healthcare Conference details: | |
| 会议： | Presentation and one-on-one meetings |
| 演讲日期： | 2024年12月3日，星期二 |
| 演讲时间： | 下午12:30 ET |
| 报告人： | 阿莉丝·瑞辛，医学博士，董事长兼首席执行官 |
| 网络直播： | 连接 |
For more information regarding one-on-one meetings, please contact your Piper Sandler representative.
有关一对一会议的更多信息，请联系您的派杰投资代表。
The live webcast can also be accessed under "Events & Presentations" on the Investors section of the Tectonic website at . Once the conference has concluded, a replay of the webcast will be available on the Company's website for approximately 90 days.
实时网络广播也可以在Tectonic网站投资者专区的“事件与演示”中访问。会议结束后，网络广播的重播将在公司网站上提供大约90天。
About Tectonic
关于Tectonic
Tectonic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its proprietary GEODe (GPCRs Engineered for Optimal Discovery) technology platform, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit and follow on LinkedIn.
Tectonic是一家处于临床阶段的生物技术公司，专注于治疗蛋白质和抗体的发现与开发，这些蛋白质和抗体可以调节G蛋白偶联受体（GPCRs）的活性。Tectonic利用其专有的GEODe（优化发现的GPCRs设计）技术平台，专注于开发生物制药，以克服现有GPCR靶向药物发现的挑战，并利用人体来改变疾病的进程。Tectonic关注重大未满足的医疗需求领域，通常在这些领域治疗选择较少或完全不存在，因为这些地方新药有潜力改善患者的生活质量。Tectonic总部位于马萨诸塞州的沃特敦。更多信息，请访问并在LinkedIn上关注。
CONTACT: Investors:
Dan Ferry
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
Media:
Kathryn Morris
The Yates Network
kathryn@theyatesnetwork.com
(914) 204-6412
联系方式：投资者：
丹·费里，电话：(617) 430-7576
LifeSci顾问
daniel@lifesciadvisors.com
(617) 430-7576
媒体:
Kathryn Morris
耶茨网络
kathryn@theyatesnetwork.com
(914) 204-6412
